110 related articles for article (PubMed ID: 17239028)
1. Successful liver transplantation and treatment of recurrent hepatitis C using pegylated alpha-interferon in a patient with Churg-Strauss disease.
Falkensammer J; Bonatti H; Dickson RC; Norman K; Nguyen J; Hinder R; Aranda-Michel J
Transpl Int; 2007 Feb; 20(2):190-4. PubMed ID: 17239028
[TBL] [Abstract][Full Text] [Related]
2. Successful pegylated interferon alpha2a monotherapy for hepatitis C virus infection in a transplanted patient who relapsed after the preceding course.
Ichikawa T; Taura N; Miyaaki H; Matsuzaki M; Eguchi S; Takatsuki M; Kanematsu T; Nakao K
Transpl Infect Dis; 2011 Aug; 13(4):438-40. PubMed ID: 21309967
[No Abstract] [Full Text] [Related]
3. Successful Hepatitis C Eradication With Preservation of Renal Function in a Liver/kidney Transplant Recipient Using Pegylated Interferon and Ribavirin.
Mukherjee S; Ariyarantha K
Transplantation; 2007 Nov; 84(10):1374-5. PubMed ID: 18049127
[No Abstract] [Full Text] [Related]
4. Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?
Roche B; Samuel D
J Hepatol; 2010 May; 52(5):630-2. PubMed ID: 20334948
[No Abstract] [Full Text] [Related]
5. Treating hepatitis C in patients with cirrhosis: the effort is worth it.
Forns X; Bruix J
J Hepatol; 2010 May; 52(5):624-6. PubMed ID: 20334945
[No Abstract] [Full Text] [Related]
6. Jaundice developing in a patient with hepatitis C4 months after liver transplantation.
Fiel MI; Schiano T
Hepatology; 2009 Feb; 49(2):695-6. PubMed ID: 19177566
[No Abstract] [Full Text] [Related]
7. Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.
Foruny JR; Bárcena R; Moreno A; Blázquez J; Manzano R; Gil-Grande LA; Moreno A; Nuño J
Transplantation; 2006 Jul; 82(2):289-90. PubMed ID: 16858295
[No Abstract] [Full Text] [Related]
8. Impact of pegylated interferon alfa-2a and ribavirin on hepatic fibrosis in liver transplant patients with recurrent hepatitis C: an open-label series.
Mukherjee S; Lyden E
Hepatogastroenterology; 2006; 53(70):561-5. PubMed ID: 16995462
[TBL] [Abstract][Full Text] [Related]
9. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.
Kontorinis N; Agarwal K; Elhajj N; Fiel MI; Schiano TD
Liver Transpl; 2006 May; 12(5):827-30. PubMed ID: 16628699
[TBL] [Abstract][Full Text] [Related]
10. Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation.
Mukherjee S
Transplant Proc; 2005 Dec; 37(10):4403-5. PubMed ID: 16387131
[TBL] [Abstract][Full Text] [Related]
11. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
[TBL] [Abstract][Full Text] [Related]
12. Pre-emptive treatment of recurrent hepatitis C infection.
Charlton M
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S50-4. PubMed ID: 12362299
[No Abstract] [Full Text] [Related]
13. Sustained resolution of fibrosing cholestatic hepatitis C despite viremic relapse after stopping pegylated interferon and ribavirin therapy.
Bolkhir A; Brunt EM; Solomon HS; Hayashi PH
Liver Transpl; 2007 Feb; 13(2):309-11; author reply 312. PubMed ID: 17260390
[No Abstract] [Full Text] [Related]
14. Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy.
Toniutto P; Fabris C; Fumo E; Apollonio L; Caldato M; Avellini C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2005 Apr; 20(4):577-82. PubMed ID: 15836706
[TBL] [Abstract][Full Text] [Related]
15. [Secondary hemophagocytic syndrome due to Peg-interferon administration].
Ruiz Ramos J
Farm Hosp; 2014 Jan; 38(1):73-4. PubMed ID: 24483865
[No Abstract] [Full Text] [Related]
16. [Treatment of recurrent hepatitis C virus infection after liver transplantation].
Lengyel G; Tulassay Z
Orv Hetil; 2007 Oct; 148(40):1875-81. PubMed ID: 17905682
[TBL] [Abstract][Full Text] [Related]
17. Treatment of recurrent hepatitis C.
Gane E
Liver Transpl; 2002 Oct; 8(10 Suppl 1):S28-37. PubMed ID: 12362295
[TBL] [Abstract][Full Text] [Related]
18. Pegylated interferon-alpha2a and ribavirin in HIV-hepatitis C coinfected patients.
Expert Rev Anti Infect Ther; 2004 Jun; 2(3):341-2. PubMed ID: 15490503
[No Abstract] [Full Text] [Related]
19. Efficacy of an escalating dose regimen of pegylated interferon alpha-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation.
Zimmermann T; Böcher WO; Biesterfeld S; Zimmermann A; Kanzler S; Greif-Higer G; Barreiros AP; Sprinzl MF; Wörns MA; Lohse AW; Mönch C; Otto G; Galle PR; Schuchmann M
Transpl Int; 2007 Jul; 20(7):583-90. PubMed ID: 17433090
[TBL] [Abstract][Full Text] [Related]
20. [Treatment with pegylated interferon and ribavirin in patients co-infected by human immunodeficiency virus and hepatitis C virus].
Marcos Sánchez F; Albo Castaño MI; Casallo Blanco S
Rev Clin Esp; 2007 Mar; 207(3):150-1; author reply 151-2. PubMed ID: 17397643
[No Abstract] [Full Text] [Related]
[Next] [New Search]
